2m 2m 2m 2m 2m 2m 2m
Vertex Pharma (VRTX)
NASDAQ
$504.42-$2.32 (-0.46%)
Price as of Oct 02, 2026 3:36 PM EDT- $128.4BMarket Cap
- 23.94%1-Year Change
- BiotechnologyIndustry
Vertex Pharma (VRTX)
$504.42-$2.32 (-0.46%)
VRTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $506.74 | ||
Change | -$16.07 (-3.07%) | ||
Open | $522.39 | ||
High | $523.51 | ||
Low | $505.27 | ||
Previous Close | $522.81 | ||
Volume | 1,194,640 | ||
30-Day Average Volume | 1,026,288 | ||
1-Week Change | -2.99% | ||
1-Month Change | -7.47% | ||
1-Year Change | 23.94% | ||
3-Year Change | 45.72% | ||
5-Year Change | 180.98% | ||
Fundamentals | |||
Shares Outstanding | 253.5M | ||
Total Assets | $27.4B | ||
Market Cap | $128.4B | ||
Enterprise Value | $122.3B | ||
Period: QTR TTM FY | |||
Revenue | $3.3B | ||
Net Income | $1.1B | ||
Free Cash Flow | $1.0B | ||
EBIT | $1.4B | ||
EBITDA | $1.4B | ||
Net Working Capital | $8.6B | ||
EPS | $4.31 | ||
Enterprise Value/EBITDA | 84 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 6 | ||
P/E | 118 | ||
PEG | 16 | ||
Price/Free Cash Flow | 127 | ||
Price/Operating Cash Flow | 114 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue